GSK3B and neoplasm: It has also been reported that prodigiosin inhibits the phosphorylation of GSK‐3β, restraining β‐catenin‐mediated Wnt activation and subsequent transcriptional activation of prosurvival genes, such as cyclin D1, slowing tumor progression in a breast cancer tumor model mice (Wang et al., 2016).